Back to search results

Xpert® Tropical Fever Test for Fever-Causing Illnesses

This study is looking at how well the Xpert Tropical Fever test works to find several fever-causing illnesses like Malaria Fever, Zika, Dengue Fever, Leptospirosis, and Chikungunya Virus Infection. The test works by detecting and identifying genetic material from these germs. You might be able to join if you are 14 years or older, have a fever, and your doctor suspects you have one of these infections. The study will measure how accurately the Xpert Tropical Fever test identifies these illnesses in blood samples taken at the beginning of the study. This study plans to include about 2500 participants, but its current recruitment status is unclear.

Study design
This is an observational study, meaning researchers will observe and collect information without giving any specific treatments. It is a multi-site, cross-sectional study that includes about 2500 participants.
What's involved
If you join, capillary and venous whole blood samples will be collected from you. These samples will be used to test for fever-causing agents.
Compensation
Not stated in the trial record.
Follow-up
The main measurement of the test's performance will be on specimens collected at the start of the study (Baseline, Day 0). Beyond this, follow-up is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07520279

Xpert® Tropical Fever Test on GeneXpert® Edge X System

Enrolling by Invitation
Not specifiedAges 14+Observational
Cepheid
~2,500 participants
Updated 2026-04-09 on ClinicalTrials.gov
What's tested:Xpert Tropical Fever test

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinical performance [PPA and NPA] of Xpert Tropical Fever
Measured over Clinical performance on specimens collected at Baseline (Day 0)

Conditions

Malaria Fever
Zika
Dengue Fever
Leptospirosis
Chikungunya Virus Infection

Explore related trials

ChikungunyaDengue FeverLeptospirosisMalariaZikaChikungunyaDengue FeverLeptospira antibodyPlasmodium sppZika virus

NCT07520279

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Naval Health Research Center

    San Diego, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Presents with AFI as defined for endemic populations or fever as defined in non-endemic populations or presents with fever as defined for nonendemic populations
Clinical suspicion of disease caused by at least one of the following: Plasmodium spp, dengue virus, Zika virus, chikungunya virus, or Leptospira (endemic population)
History of residence in or travel to an endemic geographic region within 3 months prior to specimen collection (endemic population)

Exclusion

Self-reported or known antibiotic or antimalarial use (oral or intravenous) within 3 days prior to enrollment (endemic and nonendemic population)
History of residence in or trael to endemic geographic region as defined by protocol ≤ three months prior to specimen collection (nonendemic population)
Clinical suspicion of infection caused by any of the following: Plasmodium spp., dengue virus, Zika virus, chikungunya virus, or Leptospira spp. (nonendemic population)

What this trial measures

  • Clinical performance [PPA and NPA] of Xpert Tropical FeverClinical performance on specimens collected at Baseline (Day 0)

    Evaluating the PPA and NPA of Xpert Tropical Fever relative to the comparator(s)